Non-specific bacterial and mineral-phase targets

This category refers to therapeutic targets that are not specific proteins, such as receptors or enzymes, but rather inorganic structures or broad cellular components. A primary example is the mineral phase of bone, specifically hydroxyapatite, which serves as the binding site for bisphosphonate drugs used to treat osteoporosis and Paget's disease (Drake et al., 2008). By adsorbing to these mineral surfaces, drugs can alter bone remodeling cycles or provide structural reinforcement. Similarly, non-specific bacterial targets include the general architecture of the bacterial cell wall or cytoplasmic membrane, which are targeted by antiseptics and disinfectants like chlorhexidine or iodine (McDonnell & Russell, 1999). These agents typically act through physical-chemical mechanisms, such as membrane lysis or protein precipitation, rather than by inhibiting a specific metabolic pathway. Because these targets are often inorganic or structural in nature, they are frequently classified as non-specific in pharmacological databases when a specific molecular protein target is absent or irrelevant to the drug's primary mode of action.

Other names

Mineral-phase targetsNon-specific bacterial targetsInorganic targetsPhysicochemical targets

Drugs interact via physicochemical adsorption to mineral surfaces, neutralization of chemical species, or non-specific disruption of microbial structural components.